C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
10/2002
10/29/2002	US6472404 HIV protease inhibitors
10/29/2002	US6472391 Nitrogen-containing heterocyclic compounds
10/24/2002	WO2002084656A1 Optical data carrier that contains a triazacyanine dye as the light-absorbing compound in the information layer g
10/24/2002	WO2002083842A2 Small molecule inhibitors of secretion of proteins encoded by are-mrnas
10/24/2002	WO2001053299A9 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
10/24/2002	US20020156276 Nitrogen-containing heterocyclic compounds and therapeutic agents for hyperlipidemia comprising the same
10/24/2002	US20020156109 1,4-dihydropyridine derivative with a guaiacoxypropanolamine and/or phenoxypropanolamine moiety
10/24/2002	US20020156094 Sulfonamide interleukin-1beta converting enzyme inhibitors
10/24/2002	US20020156075 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
10/24/2002	US20020156050 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors
10/24/2002	US20020155381 Multilayer; radiation transparent substrate, reflection layers, protective coatings
10/23/2002	EP1086095B1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
10/23/2002	CN1093130C Substituted pyrido 6,6-bicyclic derivatives
10/23/2002	CN1092960C Pharmaceutical composition comprising proteinase inhibitor and monoglyceride
10/22/2002	US6469193 Efficient synthesis of alkyl carbonates
10/22/2002	US6469047 Tyrosine derivatives
10/22/2002	US6469026 For therapy and prophylaxis of conditions in mammals characterized by undesired thrombosis
10/22/2002	US6469025 For the prophylaxis or treatment of a disease or disorder in a mammal in which the extravasation of leukocytes plays a role; inhibiting the binding of alpha 4 integrins to their ligands
10/22/2002	US6469024 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
10/22/2002	US6469020 Hydroxamic and carboxylic acid derivatives
10/17/2002	WO2002081443A1 Novel guanidino compounds
10/17/2002	WO2002050081A3 Antimicrobial agents
10/17/2002	US20020151566 Phosphodiesterase 4 inhibitors
10/16/2002	EP1249233A1 Npyy5 antagonists
10/16/2002	EP1248612A1 Novel compounds and compositions as protease inhibitors
10/16/2002	EP0831826B1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
10/15/2002	US6465661 Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
10/15/2002	US6465485 Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
10/15/2002	US6465483 Treating or preventing strokes; chronic inflammatory disorders such as bronchial asthma and arthritis; antiproliferative effect; ulcerative colitis and crohn's disease
10/15/2002	US6465468 Hydroxamic and carboxylic acid derivatives
10/10/2002	WO2002080164A1 Optical recording medium
10/10/2002	WO2002080163A1 Optical data carrier containing a cyclizable compound in the information layer
10/10/2002	WO2002080162A1 Optical data memories containing an axially substituted co-phthalocyanine in the information layer that can be written with light
10/10/2002	WO2002080161A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
10/10/2002	WO2002080160A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
10/10/2002	WO2002080159A1 Optical data carrier that contains a cyanine dye as the light-absorbing compound in the information layer
10/10/2002	WO2002080152A2 Optical data carrier that contains a heterocyclic azo dye as the light-absorbing compound in the information layer
10/10/2002	WO2002080150A2 Optical data medium containing, in the information layer, a dye as a lightabsorbing compound and having a protective covering layer of predetermined thickness
10/10/2002	WO2002078745A2 Use of mglur5 antagonists in the manufacture of a medicament in the treatment of autism, mental retardation, schizophrenia
10/10/2002	WO2002062764A9 Fused heterocyclic compounds
10/10/2002	WO2002062763A3 Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas
10/10/2002	US20020147342 Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
10/10/2002	DE10117464A1 Optical data medium for information recording, has cover layer and adhesive layer having preset total thickness, and recorded and readout with focussing objective lens setup having preset numerical aperture
10/09/2002	EP1246817A1 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
10/09/2002	EP1246806A1 Arly- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
10/09/2002	EP1246805A1 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
10/09/2002	EP1246803A1 Piperidine and piperazine derivatives which function as 5-ht 2a? receptor antagonists
10/09/2002	CN1373754A Antibacterial agents
10/09/2002	CN1092181C Benzyloxy substd, aromatics and their use as fungicides and insecticides
10/08/2002	US6462055 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
10/08/2002	US6462048 3-(2-(4-methylpiperazin-1-yl)-benzylidene)-1,3-dihydro-indol-2-one for example; useful as psychotherapeutic agents
10/03/2002	WO2002077984A1 Optical data carrier containing a xanthene dye in the information layer thereof as a light-absorbing compound
10/03/2002	WO2002077609A2 Identification of compounds for the treatment or prevention of proliferative diseases
10/03/2002	WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002	US20020143034 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
10/03/2002	US20020143014 Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
10/03/2002	CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/02/2002	EP1244626A2 Caspase inhibitors and uses thereof
10/02/2002	EP0871465B1 Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids
10/01/2002	US6458845 Macrophage scavenger receptor antagonists
10/01/2002	CA2272719C Apo b-secretion/mtp inhibitory amides
09/2002
09/26/2002	WO2002024636A3 N-acylsulfonamide apoptosis promoters
09/26/2002	US20020137687 Novel compounds that inhibit tryptase activity
09/25/2002	EP1243583A1 Heterocyclic compounds having sulfonamide groups
09/25/2002	EP1243577A1 Novel phenylalanine derivatives
09/25/2002	EP1242471A1 Substituted group 4 metal complexes, catalysts and olefin polymerization process
09/25/2002	EP1242427A1 Novel piperidine and piperazine derivatives
09/25/2002	EP0968179B1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides
09/25/2002	CN1371279A Metabolites of ecteinascidin 743
09/24/2002	US6455735 Reacting a tertiary or secondary amine with hydrogen peroxide in presence of a recyclable heterogeneous layered double hydroxide exchanged with one of the anions of transition metal oxides as a catalyst in a solvent
09/24/2002	US6455550 N-alkanoylphenylalanine derivatives
09/24/2002	CA2096223C Treatment for tissue ulceration
09/19/2002	WO2002071827A2 Retinoid x receptor modulators
09/19/2002	US20020132853 Diaryl piperazines and related compounds useful in the treatment of a chronic and acute pain conditions, itch and urinary incontinence.
09/19/2002	US20020132816 Estrogen agonists/antagonists for preventing breast cancer
09/19/2002	US20020132796 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid.
09/19/2002	DE10109204A1 Use of new and known diphenylurea compounds for the preparation of a medicament for the inhibition of intracellular protein-degradation pathway
09/19/2002	DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use
09/19/2002	CA2438586A1 Retinoid x receptor modulators
09/18/2002	EP0700388B1 Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors
09/17/2002	US6452009 4-unsubstituted dihydroisoquinolinone derivatives and combinatorial libraries thereof
09/12/2002	WO2002070541A2 Peptide deformylase inhibitors
09/12/2002	WO2002070473A2 Carboxamide derivatives as therapeutic agents
09/12/2002	WO2002070467A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments
09/12/2002	US20020128266 ABCA-1 elevating compounds
09/12/2002	US20020127366 Singly recordable compact disc (CD-R)
09/12/2002	CA2439827A1 Peptide deformylase inhibitors
09/11/2002	EP1237862A1 Succinate compounds, compositions and methods of use and preparation
09/10/2002	US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors
09/10/2002	US6448269 Such as 6-(n-(4-(aminoiminomethyl)benzoyl)amino)-3,4-dihydro-4,4-dimethyl-2h-1 -benzopyran-2-yl)acetic acid; inhibiting platelet aggregation or fibrinogen binding or preventing thrombosis
09/10/2002	US6448243 Serotonin antagonist for treating, ameliorating and preventing spastic paralysis or central muscle relaxants for ameliorating myotonia
09/10/2002	CA2198562C Method of treating conditions with estrogen agonists
09/10/2002	CA2195129C Substituted piperidine intermediates for producing heterocyclic-cyclic amine derivatives capable of inhibiting cholinesterase
09/10/2002	CA2059908C Process for the preparation of racemic and optically active 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid and its precursors
09/06/2002	WO2002068380A1 Synthetic excitatory amino acids
09/06/2002	WO2002007714A3 Use of anellated dihydropyridines for the preparation of pharmaceutical compositions for the treatment of chronic pain
09/04/2002	EP1236728A2 S-type 2-substituted hydroxy-2-indolinylbutyric ester compounds and process for preparation thereof
09/04/2002	EP1236719A1 Novel heterocyclic compounds and salts thereof and medicinal use of the same
09/04/2002	EP0929525B1 Heteroaryloxyethylamines as 5-ht1a receptor ligands
09/04/2002	CN1090177C Preparation of aromatic nitriles

1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 119